Stock listing

Abcellera Biologics Inc.

Selected listing: ABCL · BOATS · USD · US

Abcellera Biologics Inc. (BOATS:ABCL), Health Technology. Latest release Oct 1, 2026: AbCellera to Report Third Quarter 2026 Financial Results on November 9…

ABCL:BOATSUSDUSUpdated October 2, 2026

Ticker: BOATS:ABCL
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: BOATS
Currency: USD

About Abcellera Biologics Inc.

Abcellera Biologics Inc. is a public company traded under the ticker ABCL in the American market. Abcellera focuses on advancing its proprietary technology for antibody discovery and development.

Latest news from Abcellera Biologics Inc.

AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026

October 1, 2026

AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026

September 16, 2026

AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026

September 2, 2026

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

August 13, 2026

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

August 11, 2026

All Abcellera Biologics Inc. news →

Events

Replays

AbCellera Biologics Inc. (ABCL) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 05:00 PM ET
Watch
AbCellera Biologics Inc. (ABCL) Q1 2026 Earnings Call
Mon, May 11, 2026 · 05:00 PM ET
Watch
AbCellera Biologics Inc. (ABCL) Q4 2025 Earnings Call
Tue, Feb 24, 2026 · 05:00 PM ET
Watch

Research Abcellera Biologics Inc.

Abcellera Biologics Inc. company profile

View the public company page for Abcellera Biologics Inc. on 6ix.

Abcellera Biologics Inc. news

Read company news and market updates connected to Abcellera Biologics Inc..

Abcellera Biologics Inc. investor events

Find investor webinars, events, and replay context for Abcellera Biologics Inc..